PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 6 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,716 | -31.0% | 22,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,488 | -31.5% | 22,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3,630 | +52.3% | 22,000 | 0.0% | 0.00% | – |
| Q4 2022 | $2,383 | +138.3% | 22,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,200,000 | $1,265,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 1,982,137 | $1,140,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 94,500 | $54,000 | 0.03% |
| PRINCETON CAPITAL MANAGEMENT LLC | 25,000 | $14,000 | 0.02% |
| LUPO SECURITIES, LLC | 3,700 | $2,000 | 0.02% |
| B. Riley Wealth Advisors, Inc. | 28,000 | $17,000 | 0.00% |
| WADE G W & INC | 30,000 | $17,000 | 0.00% |
| Cannell & Co. | 90,000 | $52,000 | 0.00% |
| Focused Wealth Management, Inc | 2,955 | $2,000 | 0.00% |
| TRUST DEPARTMENT MB FINANCIAL BANK N A | 10,000 | $6,000 | 0.00% |